- This fact sheet outlines the general approach to HIV testing in Canada, although each region may have slightly different approaches to HIV testing.
- CATIE NewsThe rate of hepatitis C is on the rise among Canadian women, in particular among women aged 15 to 29 years old. Approximately 60% of new infections in this age ...
- Are you involved in the response to HIV and hepatitis C? Transforming our practice: New knowledge, new strategies Thursday, November 23 to Friday, November ...
- CATIE and the Sex Information and Education Council of Canada (SIECCAN - www.sieccan.org) collaborated to develop this guide. Design: Pam Sloan ...
- CATIE NewsPeople living with HIV are at increased risk for some cancers. This risk arises from several factors, including co-infection with viruses that have the ...
- Epclusa is a medication used to treat hepatitis C. It is approved in Canada for people with all genotypes of the hepatitis C virus.
- CATIE NewsPeople with HIV infection are at increased risk for kidney injury. This problem of injured kidneys arises for one main reason: HIV infects key cells in the ...